
Privacy notice | Accessibility statement | Terms and conditions | Login | Contact |
UK data driving real-world evidence
Bibliography
Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,700 peer-reviewed publications. The CPRD bibliography is updated on a monthly basis (last updated 6 April 2021) and papers are listed below and in the PDF below.
If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.
Download:
(PDF, 5MB, 226 pages)This work uses data provided by patients and collected by the NHS as part of their care and support. CPRD encourages researchers to use this citation in all publications using CPRD data. Find out more about acknowledging the use of patient data at the Understanding Patient Data website.
Export 74 results:
Author Title Type [ Year
Filters: Author is Garcia Rodriguez, L. A. [Clear All Filters]
“Liver disease associated with diclofenac, naproxen, and piroxicam”, Pharmacotherapy, vol. 12, pp. 207-12, 1992.
, “Nonsteroidal antiinflammatory drugs and certain rare, serious adverse events: a cohort study”, Pharmacotherapy, vol. 13, pp. 212-7, 1993.
, “Acute liver injury associated with nonsteroidal anti-inflammatory drugs and the role of risk factors”, Arch Intern Med, vol. 154, pp. 311-6, 1994.
, “Risk of gynaecomastia associated with cimetidine, omeprazole, and other antiulcer drugs”, Bmj, vol. 308, pp. 503-6, 1994.
, “Risk of upper gastrointestinal bleeding and perforation associated with individual non-steroidal anti-inflammatory drugs”, Lancet, vol. 343, pp. 769-72, 1994.
, “Ocular safety of antiulcer drugs”, Lancet, vol. 345, pp. 1059-60, 1995.
, “A cohort study of the ocular safety of anti-ulcer drugs”, Br J Clin Pharmacol, vol. 42, pp. 213-6, 1996.
, “Risk of acute liver injury associated with the combination of amoxicillin and clavulanic acid”, Arch Intern Med, vol. 156, pp. 1327-32, 1996.
, , “Gastric acid, acid-suppressing drugs, and bacterial gastroenteritis: how much of a risk?”, Epidemiology, vol. 8, pp. 571-4, 1997.
, “Hormone replacement therapy and risk of venous thromboembolism: population based case-control study”, Bmj, vol. 314, pp. 796-800, 1997.
, “Renal disease and acid-suppressing drugs”, Pharmacoepidemiol Drug Saf, vol. 6, pp. 247-51, 1997.
, “A review of epidemiologic research on drug-induced acute liver injury using the general practice research data base in the United Kingdom”, Pharmacotherapy, vol. 17, pp. 721-8, 1997.
, “The risk of acute liver injury associated with cimetidine and other acid-suppressing anti-ulcer drugs”, Br J Clin Pharmacol, vol. 43, pp. 183-8, 1997.
, “Antiepileptics and blood dyscrasias: a cohort study”, Pharmacotherapy, vol. 18, pp. 1277-83, 1998.
, “Comparison of mortality from peptic ulcer bleed between patients with or without peptic ulcer antecedents”, Epidemiology, vol. 9, pp. 452-6, 1998.
, “Presence of diabetes related complication at the time of NIDDM diagnosis: an important prognostic factor”, Eur J Epidemiol, vol. 14, pp. 439-45, 1998.
, “Recent epidemiological studies of the association between hormone replacement therapy and venous thromboembolism. A review”, Drug Saf, vol. 18, pp. 117-23, 1998.
, “Risk of hospitalization for upper gastrointestinal tract bleeding associated with ketorolac, other nonsteroidal anti-inflammatory drugs, calcium antagonists, and other antihypertensive drugs”, Arch Intern Med, vol. 158, pp. 33-9, 1998.
, “Use of the UK General Practice Research Database for pharmacoepidemiology”, Br J Clin Pharmacol, vol. 45, pp. 419-25, 1998.
, “A cohort study on the risk of acute liver injury among users of ketoconazole and other antifungal drugs”, Br J Clin Pharmacol, vol. 48, pp. 847-52, 1999.
, “One-year follow-up of newly diagnosed irritable bowel syndrome patients”, Aliment Pharmacol Ther, vol. 13, pp. 1097-102, 1999.
, “Secondary prevention of upper gastrointestinal bleeding associated with maintenance acid-suppressing treatment in patients with peptic ulcer bleed”, Epidemiology, vol. 10, pp. 228-32, 1999.
, “Use of cimetidine, omeprazole, and ranitidine in pregnant women and pregnancy outcomes”, Am J Epidemiol, vol. 150, pp. 476-81, 1999.
, “Are schizophrenia or antipsychotic drugs a risk factor for cataracts?”, Epidemiology, vol. 11, pp. 620-3, 2000.
, “Detection of colorectal tumor and inflammatory bowel disease during follow-up of patients with initial diagnosis of irritable bowel syndrome”, Scand J Gastroenterol, vol. 35, pp. 306-11, 2000.
, “Differential effects of aspirin and non-aspirin nonsteroidal antiinflammatory drugs in the primary prevention of myocardial infarction in postmenopausal women”, Epidemiology, vol. 11, pp. 382-7, 2000.
, “Overall mortality among patients surviving an episode of peptic ulcer bleeding”, J Epidemiol Community Health, vol. 54, pp. 130-3, 2000.
, , “Gender and drug treatment as determinants of mortality in a cohort of heart failure patients”, Eur J Epidemiol, vol. 17, pp. 329-35, 2001.
, “Incidence of newly diagnosed heart failure in UK general practice”, Eur J Heart Fail, vol. 3, pp. 225-31, 2001.
, “Relative risk of upper gastrointestinal complications among users of acetaminophen and nonsteroidal anti-inflammatory drugs”, Epidemiology, vol. 12, pp. 570-6, 2001.
, “The risk of obstructive airways disease in a glaucoma population”, Pharmacoepidemiol Drug Saf, vol. 10, pp. 157-63, 2001.
, “Risk of upper gastrointestinal bleeding and perforation associated with low-dose aspirin as plain and enteric-coated formulations”, BMC Clin Pharmacol, vol. 1, p. 1, 2001.
, , “Respiratory medications and risk of asthma death”, Thorax, vol. 57, pp. 683-6, 2002.
, “Risk of acute liver injury in patients with diabetes”, Pharmacotherapy, vol. 22, pp. 1091-6, 2002.
, “Risk of clinical blood dyscrasia in a cohort of antibiotic users”, Pharmacotherapy, vol. 22, pp. 630-6, 2002.
, “Risk of irritable bowel syndrome among asthma patients”, Pharmacoepidemiol Drug Saf, vol. 11, pp. 31-5, 2002.
, “Risk of mortality in a cohort of patients newly diagnosed with chronic atrial fibrillation”, BMC Cardiovasc Disord, vol. 2, p. 5, 2002.
, “Is hormone replacement therapy associated with an increased risk of irritable bowel syndrome?”, Maturitas, vol. 44, pp. 133-40, 2003.
, “Nonsteroidal antiinflammatory drugs as a trigger of clinical heart failure”, Epidemiology, vol. 14, pp. 240-6, 2003.
, “Users of oral steroids are at a reduced risk of developing irritable bowel syndrome”, Pharmacoepidemiol Drug Saf, vol. 12, pp. 583-8, 2003.
, “Validity of the general practice research database”, Pharmacotherapy, vol. 23, pp. 686-9, 2003.
, “Acute and clinically relevant drug-induced liver injury: a population based case-control study”, Br J Clin Pharmacol, vol. 58, pp. 71-80, 2004.
, “Breast cancer incidence and use of antihypertensive medication in women”, Pharmacoepidemiol Drug Saf, vol. 13, pp. 581-5, 2004.
, “Inverse association between nonsteroidal anti-inflammatory drugs and prostate cancer”, Cancer Epidemiol Biomarkers Prev, vol. 13, pp. 649-53, 2004.
, “Natural history of gastro-oesophageal reflux disease diagnosed in general practice”, Aliment Pharmacol Ther, vol. 20, pp. 751-60, 2004.
, “Risk of breast cancer among users of aspirin and other anti-inflammatory drugs”, Br J Cancer, vol. 91, pp. 525-9, 2004.
, “Breast cancer risk among users of antidepressant medications”, Epidemiology, vol. 16, pp. 101-5, 2005.
,